Nurix Therapeutics Inc (NRIX) — Cash Flow Quality Index
Latest as of May 2020:
-1.90x
Nurix Therapeutics Inc (NRIX) has a Cash Flow Quality Index of -1.90x as of May 2020. Operating cash flow of $-14.43 Million is below net income of $7.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Nurix Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-1.90x
Operating CF / Net Income
Operating Cash Flow
$-14.43 Million
USD
Net Income
$7.58 Million
USD
Data as of
May 2020
Most recent filing
Annual Cash Flow Quality Index for Nurix Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Nurix Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.